FONT-SIZE Plus   Neg

RTI Biologics To Buy Pioneer Surgical Technology - Quick Facts

RTI Biologics Inc. (RTIX), a provider of orthopedic and other biologic implants, plans to acquire privately held Pioneer Surgical Technology, headquartered in Marquette, Mich. The Pioneer acquisition supports RTI's strategic initiatives to expand its current implant portfolio into metals and synthetics and to grow direct distribution.

Pursuant to the merger agreement, RTI would pay $130 million cash to acquire Pioneer's outstanding stock. RTI said it has received a commitment from TD Bank, N.A., TD Securities "USA" LLC and Regions Bank for a 5-year, $80 million senior secured facility, including a $60 million term loan and a $20 million revolving credit facility. Further, RTI has agreed to a $50 million private placement of convertible preferred equity with Water Street, a healthcare-focused private equity firm.

RTI's president and chief executive stated, "This acquisition will bring immediate scale, allowing us to reach our strategic goals and take advantage of growth opportunities more quickly than either company could do independently."

The transaction, which may close in the third quarter of 2013, would be funded via. a combination of cash on hand, a new credit facility and a concurrent private placement of convertible preferred equity from Water Street Healthcare Partners.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT